Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation

Neoplasia. 2021 Nov;23(11):1123-1136. doi: 10.1016/j.neo.2021.09.006. Epub 2021 Oct 21.

Abstract

The fallopian tube fimbrial epithelium, which is exposed to the follicular fluid (FF) contents of ovulation, is regarded as the main origin of ovarian high-grade serous carcinoma. Previously, we found that growth factors in FF, such as IGF2, are responsible for the malignant transformation of fallopian tube epithelium. However, ovulation is a monthly transient event, whereas carcinogenesis requires continuous, long-term exposure. Here, we found the transformation activity of FF sustained for more than 30 days after drainage into the peritoneal fluid (PF). Hepatocyte growth factor (HGF), activated through the ovulation injury-tissue factor-thrombin-HGF activator (HGFA)-HGF cleavage cascade confers a sustained transformation activity to fallopian tube epithelium, high-grade serous carcinoma. Physiologically, the high reserve of the coagulation-HGF cascade sources a sustained level of HGF in PF, then to the blood circulation. This HGF axis promotes the growth of the corpus luteum and repair of tissue injury after ovulation.

Keywords: Coagulation; Follicular fluid; Hepatocyte growth factor; High-grade serous carcinoma; Ovulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Apoptosis
  • Cell Proliferation
  • Cell Transformation, Neoplastic / metabolism
  • Cell Transformation, Neoplastic / pathology*
  • Cells, Cultured
  • Corpus Luteum / injuries
  • Corpus Luteum / physiology*
  • Cystadenocarcinoma, Serous / metabolism
  • Cystadenocarcinoma, Serous / pathology*
  • Fallopian Tube Neoplasms / metabolism
  • Fallopian Tube Neoplasms / pathology*
  • Female
  • Follicular Fluid / metabolism
  • Hepatocyte Growth Factor / metabolism
  • Humans
  • Insulin-Like Growth Factor II / metabolism
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / pathology*
  • Ovulation*
  • Peptide Hydrolases / metabolism*
  • Prognosis
  • Serine Endopeptidases / metabolism
  • Thrombin / metabolism
  • Thromboplastin / metabolism
  • Xenograft Model Antitumor Assays

Substances

  • HGF protein, human
  • IGF2 protein, human
  • Hepatocyte Growth Factor
  • Insulin-Like Growth Factor II
  • Thromboplastin
  • Peptide Hydrolases
  • HGF activator
  • Serine Endopeptidases
  • Thrombin